At 09:15 am, around 6.76 million shares, representing 13.5 per cent of the healthcare services company's total equity, changed hands on the BSE, the exchange data shows. The names of the buyers were not ascertained immediately.
According to media reports, private equity giant Carlyle was set to sell stake in Metropolis Healthcare via block deal.
As on December 31, 2019, investor CA Lotus Investments, a subsidiary of US-based private equity firm Carlyle Group, held 7.18 million shares, or 14.31 per cent stake, in Metropolis Healthcare, the shareholding pattern data shows.
The stock has corrected 45 per cent from its all-time high level of Rs 2,110, touched on March 3, 2020. The company had debuted at the bourses in April last year after raising Rs 1,204 crore through its initial public offering (IPO), at issue price of Rs 880 per share.
At 09:30 am, Metropolis Healthcare was trading 10 per cent lower at Rs 1,203 on the BSE, as compared to 1.6 per cent rise in the S&P BSE Sensex. A combined 78.7 million shares have changed hands on the counter on the NSE and BSE so far.
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
-
Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
-
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in